Russell Investments Group, Ltd. Bluebird Bio, Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 326 shares of BLUE stock, worth $2,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
326
Previous 13,628 97.61%
Holding current value
$2,741
Previous $13,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.47 - $1.35 $6,251 - $17,957
-13,302 Reduced 97.61%
326 $0
Q2 2024

Aug 08, 2024
BUY
$0.85 - $1.26 $11,583 - $17,171
13,628 New
13,628 $13,000
Q4 2023

Feb 05, 2024
SELL
$1.32 - $4.83 $18,449 - $67,508
-13,977 Reduced 14.18%
84,601 $116,000
Q3 2023

Nov 13, 2023
SELL
$3.02 - $4.05 $1,751 - $2,349
-580 Reduced 0.58%
98,578 $299,000
Q2 2023

Aug 10, 2023
BUY
$2.79 - $5.03 $823 - $1,483
295 Added 0.3%
99,158 $326,000
Q1 2023

May 09, 2023
BUY
$3.14 - $8.22 $107,771 - $282,126
34,322 Added 53.18%
98,863 $314,000
Q4 2022

Feb 08, 2023
BUY
$5.77 - $8.49 $258,005 - $379,630
44,715 Added 225.54%
64,541 $446,000
Q3 2022

Nov 04, 2022
SELL
$3.75 - $7.39 $13,567 - $26,737
-3,618 Reduced 15.43%
19,826 $123,000
Q2 2022

Jul 29, 2022
SELL
$2.94 - $5.23 $139,694 - $248,503
-47,515 Reduced 66.96%
23,444 $96,000
Q1 2022

May 05, 2022
SELL
$4.07 - $10.6 $83,089 - $216,399
-20,415 Reduced 22.34%
70,959 $342,000
Q4 2021

Jan 21, 2022
SELL
$8.96 - $16.31 $287,060 - $522,539
-32,038 Reduced 25.96%
91,374 $912,000
Q3 2021

Nov 08, 2021
SELL
$11.24 - $21.0 $104,588 - $195,405
-9,305 Reduced 7.01%
123,412 $2.36 Million
Q2 2021

Aug 04, 2021
SELL
$18.04 - $22.09 $1.94 Million - $2.38 Million
-107,526 Reduced 44.76%
132,717 $4.24 Million
Q1 2021

May 10, 2021
BUY
$16.59 - $33.89 $332,231 - $678,681
20,026 Added 9.09%
240,243 $7.24 Million
Q4 2020

Feb 08, 2021
BUY
$27.5 - $37.92 $791,312 - $1.09 Million
28,775 Added 15.03%
220,217 $9.54 Million
Q3 2020

Nov 09, 2020
BUY
$34.44 - $43.75 $1.52 Million - $1.93 Million
44,180 Added 30.0%
191,442 $10.3 Million
Q2 2020

Aug 05, 2020
BUY
$27.12 - $45.97 $2.25 Million - $3.81 Million
82,877 Added 128.72%
147,262 $8.98 Million
Q1 2020

May 06, 2020
BUY
$26.16 - $63.5 $1.34 Million - $3.25 Million
51,107 Added 384.9%
64,385 $2.96 Million
Q4 2019

Jan 29, 2020
SELL
$46.96 - $61.67 $457,484 - $600,789
-9,742 Reduced 42.32%
13,278 $1.16 Million
Q3 2019

Nov 01, 2019
BUY
$59.47 - $93.1 $338,146 - $529,366
5,686 Added 32.8%
23,020 $2.11 Million
Q2 2019

Aug 09, 2019
SELL
$75.84 - $105.21 $357,130 - $495,433
-4,709 Reduced 21.36%
17,334 $2.21 Million
Q1 2019

May 13, 2019
BUY
$64.44 - $104.11 $151,562 - $244,866
2,352 Added 11.94%
22,043 $3.47 Million
Q4 2018

Feb 11, 2019
BUY
$59.1 - $93.26 $990,811 - $1.56 Million
16,765 Added 572.97%
19,691 $1.95 Million
Q3 2018

Oct 26, 2018
SELL
$88.86 - $117.49 $1.39 Million - $1.84 Million
-15,650 Reduced 84.25%
2,926 $427,000
Q2 2018

Aug 08, 2018
SELL
$99.64 - $127.59 $443,398 - $567,775
-4,450 Reduced 19.33%
18,576 $2.92 Million
Q1 2018

May 11, 2018
SELL
$105.8 - $150.94 $212,234 - $302,785
-2,006 Reduced 8.01%
23,026 $3.93 Million
Q4 2017

Feb 06, 2018
SELL
$81.25 - $130.7 $1.03 Million - $1.65 Million
-12,625 Reduced 33.53%
25,032 $4.5 Million
Q3 2017

Nov 07, 2017
BUY
$57.74 - $91.42 $2.17 Million - $3.44 Million
37,657
37,657 $5.17 Million

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $649M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email